TR200000369T2 - Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi. - Google Patents

Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.

Info

Publication number
TR200000369T2
TR200000369T2 TR2000/00369T TR200000369T TR200000369T2 TR 200000369 T2 TR200000369 T2 TR 200000369T2 TR 2000/00369 T TR2000/00369 T TR 2000/00369T TR 200000369 T TR200000369 T TR 200000369T TR 200000369 T2 TR200000369 T2 TR 200000369T2
Authority
TR
Turkey
Prior art keywords
treatment
production
rheumatic diseases
pharmaceutical preparations
combined pharmaceutical
Prior art date
Application number
TR2000/00369T
Other languages
English (en)
Inventor
Lehmann Paul
Peter Kaltwasser Joachim
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR200000369T2 publication Critical patent/TR200000369T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu bulus, romatizmal hastaliklarin tedavisi amaciyla kombine farmasötik prepatlarin hazirlanmasi için bir eritropoitein preparati ile fizyolojik olarak uygun olan ve 1-40 mg demir iyonuna tekabül eden demir preparatinin bireysel verilis biçiminde kullanilmasi ile ilgilidir.
TR2000/00369T 1997-08-08 1998-08-05 Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi. TR200000369T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19734293A DE19734293A1 (de) 1997-08-08 1997-08-08 Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen

Publications (1)

Publication Number Publication Date
TR200000369T2 true TR200000369T2 (tr) 2000-09-21

Family

ID=7838328

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00369T TR200000369T2 (tr) 1997-08-08 1998-08-05 Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.

Country Status (15)

Country Link
US (1) US6372715B1 (tr)
EP (1) EP1037648B1 (tr)
JP (3) JP2001513510A (tr)
KR (1) KR100478573B1 (tr)
CN (1) CN1170589C (tr)
AT (1) ATE263571T1 (tr)
AU (1) AU738027B2 (tr)
BR (1) BR9811086A (tr)
CA (1) CA2297959C (tr)
DE (2) DE19734293A1 (tr)
DK (1) DK1037648T3 (tr)
ES (1) ES2218851T3 (tr)
PT (1) PT1037648E (tr)
TR (1) TR200000369T2 (tr)
WO (1) WO1999007401A2 (tr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222118T1 (de) * 1997-03-18 2002-08-15 Roche Diagnostics Gmbh Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
ATE291436T2 (de) * 2000-05-15 2005-04-15 Hoffmann La Roche Flüssige arzneizubereitung enthaltend ein erythropoietin derivat
US6929954B2 (en) * 2000-11-02 2005-08-16 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
CN1473265B (zh) * 2000-11-02 2011-10-12 色品先进技术股份有限公司 生产纯化的补血铁-糖复合物的方法及产品的生产
MXPA03005406A (es) 2000-12-20 2003-09-25 Hoffmann La Roche Conjugados de eritropoyetina.
EP1909106B1 (en) 2001-09-14 2013-01-02 F. Hoffmann-La Roche AG Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
SI1848446T1 (sl) * 2005-02-09 2010-01-29 Vifor Int Ag Uporaba Ĺľelezove(III)-kompleksne spojine
AU2006246721B2 (en) 2005-05-16 2012-12-13 Abbvie Biotechnology Ltd Use of TNF inhibitor for treatment of erosive polyarthritis
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
WO2007120656A2 (en) * 2006-04-10 2007-10-25 Abbott Biotechnology Ltd. Uses and compositions for treatment of rheumatoid arthritis
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
US20080131374A1 (en) * 2006-04-19 2008-06-05 Medich John R Uses and compositions for treatment of rheumatoid arthritis
SI2054074T1 (sl) 2006-08-04 2014-12-31 Prolong Pharmaceuticals Llc Modificiran eritropoetin
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
US20100040630A1 (en) * 2008-03-24 2010-02-18 Aake Elden Methods and compositions for treating bone loss
WO2010086832A2 (en) * 2009-01-30 2010-08-05 Ecolab Inc. Development of an aluminum hydroxycarboxylate builder
US8202830B2 (en) 2009-01-30 2012-06-19 Ecolab Usa Inc. Development of an aluminum hydroxydicarboxylate builder
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
JP6085401B2 (ja) * 2014-07-25 2017-02-22 原　和弘 薬剤投与情報提供装置及び薬剤投与情報提供のためのコンピュータプログラム
HUE052634T2 (hu) 2015-11-23 2021-05-28 Bristol Myers Squibb Co Adalékrendszerek felhasználásra protein pegilálásban

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194947A (en) * 1979-09-18 1983-06-14 C Holland Composition containing calcium and ferrous ions for treatment of rheumatoid arthritis
US4732889A (en) 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
ATE251912T1 (de) * 1994-11-03 2003-11-15 Roche Diagnostics Gmbh Verwendung des erythropoietins zur behandlung von rheumatoider arthritis
DE19535571A1 (de) 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen

Also Published As

Publication number Publication date
JP2001513510A (ja) 2001-09-04
DK1037648T3 (da) 2004-08-02
BR9811086A (pt) 2000-08-29
KR20010022738A (ko) 2001-03-26
EP1037648B1 (de) 2004-04-07
AU9159098A (en) 1999-03-01
CN1268058A (zh) 2000-09-27
CA2297959A1 (en) 1999-02-18
AU738027B2 (en) 2001-09-06
ES2218851T3 (es) 2004-11-16
CA2297959C (en) 2011-11-29
DE19734293A1 (de) 1999-02-11
EP1037648A2 (de) 2000-09-27
WO1999007401A2 (de) 1999-02-18
WO1999007401A3 (de) 1999-04-29
DE59811158D1 (de) 2004-05-13
PT1037648E (pt) 2004-08-31
JP2012012410A (ja) 2012-01-19
JP2008133290A (ja) 2008-06-12
ATE263571T1 (de) 2004-04-15
US6372715B1 (en) 2002-04-16
KR100478573B1 (ko) 2005-03-28
CN1170589C (zh) 2004-10-13

Similar Documents

Publication Publication Date Title
TR200000369T2 (tr) Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.
HRP20020088B1 (hr) Levodopa/karbidopa/entakapon farmaceutski pripravak
BRPI0015284B8 (pt) formulações de hidrocodona de liberação controlada
MX171191B (es) Composiciones farmaceuticas de glipizida
NZ503946A (en) Oral dosage form in an oval or caplet shape for administration of bisphosphonates and other known medicaments
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
MX9700081A (es) Composiciones farmaceuticas de tacrina.
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
TR200002207T1 (tr) Slekoksib bileşikleri.
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
AR032293A1 (es) Estuche farmaceutico
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
ES2174107T3 (es) Preparaciones combinadas framaceuticas que contienen eritropoyetina y preparaciones de hierro.
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
GR1002847B (el) Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
MXPA04001912A (es) Aminobenzofenonas novedosas.
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
AR029160A1 (es) El uso del interferon-alfa pegilado para la preparacion de un medicamento para el tratamiento del carcinoma de celula renal, un kit y el uso del mismo
BE1002256A3 (fr) Medicaments.